213 related articles for article (PubMed ID: 35412415)
1. Immunotherapy in soft tissue sarcoma: current evidence and future perspectives in a variegated family of different tumor.
Baldi GG; Gronchi A; Tazzari M; Stacchiotti S
Expert Rev Anticancer Ther; 2022 May; 22(5):491-503. PubMed ID: 35412415
[TBL] [Abstract][Full Text] [Related]
2. Emerging Trends in Immunotherapy for Adult Sarcomas.
Husain M; Chen L; Liebner D; Beane J; Rubinstein M; Pollock R; Verschraegen C; Tinoco G
Oncologist; 2023 May; 28(5):e233-e241. PubMed ID: 36905579
[TBL] [Abstract][Full Text] [Related]
3. The Role of Immunotherapy in the Management of Soft Tissue Sarcomas: Current Landscape and Future Outlook.
Banks LB; D'Angelo SP
J Natl Compr Canc Netw; 2022 Jul; 20(7):834-844. PubMed ID: 35830892
[TBL] [Abstract][Full Text] [Related]
4. Next frontiers in systemic therapy for soft tissue sarcoma.
Yen CC; Chen TW
Chin Clin Oncol; 2018 Aug; 7(4):43. PubMed ID: 30173533
[TBL] [Abstract][Full Text] [Related]
5. Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention.
Tazzari M; Bergamaschi L; De Vita A; Collini P; Barisella M; Bertolotti A; Ibrahim T; Pasquali S; Castelli C; Vallacchi V
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299136
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
Nathenson MJ; Conley AP; Sausville E
Oncologist; 2018 Jan; 23(1):71-83. PubMed ID: 28935774
[TBL] [Abstract][Full Text] [Related]
7. Role of Virus-Directed Therapy in Soft Tissue Sarcoma.
Chaudhary H; D'Angelo S
Curr Treat Options Oncol; 2022 Mar; 23(3):404-414. PubMed ID: 35258792
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond.
Fazel M; Dufresne A; Vanacker H; Waissi W; Blay JY; Brahmi M
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980528
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for sarcomas.
Nakata E; Fujiwara T; Kunisada T; Ito T; Takihira S; Ozaki T
Jpn J Clin Oncol; 2021 Apr; 51(4):523-537. PubMed ID: 33611603
[TBL] [Abstract][Full Text] [Related]
10. The Landscape of Immunotherapy for Retroperitoneal Sarcoma.
Gingrich AA; Nassif EF; Roland CL; Keung EZ
Curr Oncol; 2023 Feb; 30(2):2144-2158. PubMed ID: 36826126
[TBL] [Abstract][Full Text] [Related]
11. The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy.
Crombé A; Roulleau-Dugage M; Italiano A
Cancer Commun (Lond); 2022 Dec; 42(12):1288-1313. PubMed ID: 36260064
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in Sarcoma: Where Do Things Stand?
Moreno Tellez C; Leyfman Y; D'Angelo SP; Wilky BA; Dufresne A
Surg Oncol Clin N Am; 2022 Jul; 31(3):381-397. PubMed ID: 35715140
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy and targeted treatments of breast sarcoma by histologic subtype.
Kokkali S; Stravodimou A; Duran-Moreno J; Koufopoulos N; Voutsadakis IA; Digklia A
Expert Rev Anticancer Ther; 2021 Jun; 21(6):591-604. PubMed ID: 33554686
[No Abstract] [Full Text] [Related]
14. New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas.
Seong G; D'Angelo SP
Front Oncol; 2023; 13():1150765. PubMed ID: 37007160
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in soft-tissue sarcoma.
Ayodele O; Razak ARA
Curr Oncol; 2020 Feb; 27(Suppl 1):17-23. PubMed ID: 32174754
[TBL] [Abstract][Full Text] [Related]
16. PD1/PD-L1 targeting in advanced soft-tissue sarcomas: a pooled analysis of phase II trials.
Italiano A; Bellera C; D'Angelo S
J Hematol Oncol; 2020 May; 13(1):55. PubMed ID: 32430039
[TBL] [Abstract][Full Text] [Related]
17. Metastatic soft tissue sarcoma: current treatment landscape and future perspectives.
Skafida E; Kokkali S; Nikolaou M; Digklia A
Expert Rev Anticancer Ther; 2017 Jun; 17(6):537-543. PubMed ID: 28425820
[TBL] [Abstract][Full Text] [Related]
18. The current reality of soft tissue sarcomas: advances, controversies, areas for improvement, and promising new treatments.
Blay JY; Le Cesne A; Demetri GD
Expert Rev Anticancer Ther; 2020 Apr; 20(sup1):29-39. PubMed ID: 32349562
[No Abstract] [Full Text] [Related]
19. Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study.
Spalato-Ceruso M; Bouteiller F; Guegan JP; Toulmonde M; Bessede A; Kind M; Cousin S; Buy X; Palussiere J; Le Loarer F; Dadone-Montaudie B; Pulido M; Italiano A
J Hematol Oncol; 2022 Oct; 15(1):157. PubMed ID: 36303228
[TBL] [Abstract][Full Text] [Related]
20. Role of Immunotherapy in Sarcomas.
Dalal S; Shan KS; Thaw Dar NN; Hussein A; Ergle A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
